| Net Cash Provided by (Used in) Operating Activities |
-7.75M |
USD |
-258% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
17M |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
150M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
105M |
shares |
-0.38% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
9.28M |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
83.2M |
USD |
+26.1% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
17.7M |
USD |
+13.5% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
4.6M |
USD |
-38.7% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
1.84B |
USD |
-0.26% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
86.5M |
USD |
+34% |
Q1 2024 |
Q1 2024 |